PIERIS PHARMACEUTICALS, INC. Quarterly Common Stock, Shares, Issued from Q2 2013 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Pieris Pharmaceuticals, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q2 2013 to Q3 2024.
  • Pieris Pharmaceuticals, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 1.32M shares, a 98.7% decline year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 1.32M -97.5M -98.7% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 1.32M -97.5M -98.7% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 1.24M -73.3M -98.3% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 1.24M -73.3M -98.3% Dec 31, 2023 10-Q 2024-11-13
Q3 2023 98.9M +24.4M +32.9% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 98.9M +24.6M +33.1% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 74.5M +421K +0.57% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 74.5M +2.3M +3.18% Dec 31, 2022 10-K 2024-03-29
Q3 2022 74.4M +2.9M +4.06% Sep 30, 2022 10-Q 2022-11-04
Q2 2022 74.3M +7.58M +11.4% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 74.1M +14.4M +24.1% Mar 31, 2022 10-Q 2022-05-11
Q4 2021 72.2M +16.2M +29% Dec 31, 2021 10-K 2023-03-31
Q3 2021 71.5M +15.5M +27.8% Sep 30, 2021 10-Q 2021-11-02
Q2 2021 66.7M +14.3M +27.3% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 59.7M +4.51M +8.16% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 56M +790K +1.43% Dec 31, 2020 10-K 2022-03-02
Q3 2020 56M +6.58M +13.3% Sep 30, 2020 10-Q 2020-11-04
Q2 2020 52.4M +3.14M +6.37% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 55.2M +6.06M +12.3% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 55.2M +1.06M +1.96% Dec 31, 2019 10-K 2021-03-31
Q3 2019 49.4M -4.76M -8.79% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 49.3M -4.75M -8.79% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 49.2M -4.82M -8.94% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 54.2M +9.13M +20.3% Dec 31, 2018 10-K 2020-03-13
Q3 2018 54.1M +9.44M +21.1% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 54M +10.2M +23.2% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 54M +10.9M +25.4% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 45M +1.96M +4.55% Dec 31, 2017 10-K 2019-03-18
Q3 2017 44.7M +1.65M +3.82% Sep 30, 2017 10-Q 2017-11-13
Q2 2017 43.8M +782K +1.82% Jun 30, 2017 10-Q 2017-08-11
Q1 2017 43.1M +3.23M +8.1% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 43.1M +3.23M +8.1% Dec 31, 2016 10-K 2018-03-15
Q3 2016 43.1M +3.3M +8.3% Sep 30, 2016 10-Q 2016-11-10
Q2 2016 43.1M +13.6M +46.3% Jun 30, 2016 10-Q 2016-08-11
Q1 2016 39.8M +10.4M +35.4% Mar 31, 2016 10-Q 2016-05-12
Q4 2015 39.8M +10.6M +36% Dec 31, 2015 10-K 2017-03-30
Q3 2015 39.8M +33.7M +552% Sep 30, 2015 10-Q 2015-11-13
Q2 2015 29.4M +23.3M +382% Jun 30, 2015 10-Q 2015-08-13
Q1 2015 29.4M +24.4M +489% Mar 31, 2015 10-Q 2015-05-14
Q4 2014 29.3M +17.5M +148% Dec 31, 2014 10-K 2016-03-23
Q3 2014 6.1M Sep 30, 2014 10-Q/A 2014-12-12
Q2 2014 6.1M +1.1M +22% Jun 30, 2014 10-Q/A 2014-12-12
Q1 2014 5M Mar 31, 2014 10-Q 2014-06-02
Q4 2013 11.8M Dec 31, 2013 10-K 2015-03-30
Q2 2013 5M Jun 30, 2013 10-K 2014-09-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.